|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3630200A
(en)
|
1969-06-09 |
1971-12-28 |
Alza Corp |
Ocular insert
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
JPS608117B2
(ja)
|
1977-02-08 |
1985-02-28 |
財団法人微生物化学研究会 |
新生理活性物質エステラスチンおよびその製造法
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
JPS57151944A
(en)
|
1981-03-16 |
1982-09-20 |
Fuji Photo Film Co Ltd |
Color photosensitive silver halide material
|
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
US4452813A
(en)
|
1981-05-22 |
1984-06-05 |
Taiho Pharmaceutical Company Limited |
Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
|
|
JPS58193541A
(ja)
|
1982-05-07 |
1983-11-11 |
Konishiroku Photo Ind Co Ltd |
熱現像画像記録材料
|
|
JPH0245181B2
(ja)
|
1983-03-16 |
1990-10-08 |
Fuji Photo Film Co Ltd |
Netsugenzokaraakankozairyo
|
|
GB8313322D0
(en)
|
1983-05-14 |
1983-06-22 |
Ciba Geigy Ag |
Heterocyclic-(cyclo)aliphatic carboxylic acids
|
|
GB8313321D0
(en)
|
1983-05-14 |
1983-06-22 |
Ciba Geigy Ag |
Preparation of mercaptan substituted carboxylic acids
|
|
GB8313320D0
(en)
|
1983-05-14 |
1983-06-22 |
Ciba Geigy Ag |
Coating compositions
|
|
CA1247547A
(en)
|
1983-06-22 |
1988-12-28 |
Paul Hadvary |
Leucine derivatives
|
|
GB8412063D0
(en)
|
1984-05-11 |
1984-06-20 |
Ciba Geigy Ag |
Compositions containing heterocyclic corrosion inhibitors
|
|
GB8412065D0
(en)
|
1984-05-11 |
1984-06-20 |
Ciba Geigy Ag |
Preparation of carboxylic acid derivatives
|
|
GB8412064D0
(en)
|
1984-05-11 |
1984-06-20 |
Ciba Geigy Ag |
Compositions containing heterocyclic corrosion inhibitors
|
|
US4851423A
(en)
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
US5391571A
(en)
|
1989-11-15 |
1995-02-21 |
American Home Products Corporation |
Cholesterol ester hydrolase inhibitors
|
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
|
JPH0427854A
(ja)
|
1990-05-23 |
1992-01-30 |
Mitsubishi Heavy Ind Ltd |
レーザ分析装置
|
|
EP0584222B1
(en)
|
1991-05-10 |
1997-10-08 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
|
AU5118893A
(en)
|
1992-10-13 |
1994-05-09 |
Nippon Soda Co., Ltd. |
Oxazole and thiazole derivatives
|
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
|
JPH06298731A
(ja)
|
1993-04-13 |
1994-10-25 |
Fuji Photo Film Co Ltd |
複素環化合物の製造方法
|
|
DE4326151A1
(de)
|
1993-08-04 |
1995-02-09 |
Hoechst Ag |
Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
|
CA2134192A1
(en)
|
1993-11-12 |
1995-05-13 |
Michael L. Denney |
5, 6-bicyclic glycoprotein iib/iiia antagonists
|
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
WO1995029897A1
(en)
|
1994-04-29 |
1995-11-09 |
G.D. Searle & Co. |
METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
|
|
AU690302B2
(en)
|
1994-06-30 |
1998-04-23 |
Dade Behring Inc. |
Bioactive porous partition members
|
|
HUT78089A
(hu)
|
1994-11-07 |
1999-08-30 |
Pfizer Inc. |
Neuropeptid Y1 receptorokhoz szelektíven kötődő szubsztituált piperazin-származékok
|
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
WO1996023515A1
(en)
|
1995-01-31 |
1996-08-08 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
CA2211656A1
(en)
|
1995-01-31 |
1996-08-08 |
Margret B. Basinski |
Anti-obesity proteins
|
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
|
CA2204616C
(en)
|
1995-09-18 |
2002-12-17 |
Ranjan Mukherjee |
Ppar gamma antagonists for treating obesity
|
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
|
AU7692696A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Heteroaryl derivatives
|
|
WO1997019682A1
(en)
|
1995-12-01 |
1997-06-05 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
|
WO1997020822A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Quinazolin-2,4-diazirines as npy receptor antagonist
|
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
|
JP2000504021A
(ja)
|
1996-02-02 |
2000-04-04 |
メルク エンド カンパニー インコーポレーテッド |
糖尿病及び関連疾患状態を治療する方法
|
|
DE69728267T2
(de)
|
1996-02-02 |
2005-02-24 |
Merck & Co., Inc. |
Antidiabetisches mittel
|
|
ATE236137T1
(de)
|
1996-02-02 |
2003-04-15 |
Merck & Co Inc |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
|
AU721452B2
(en)
|
1996-02-02 |
2000-07-06 |
Merck & Co., Inc. |
Antidiabetic agents
|
|
AU1856997A
(en)
|
1996-02-02 |
1997-08-22 |
Merck & Co., Inc. |
Method for raising hdl cholesterol levels
|
|
WO1997029079A1
(en)
|
1996-02-06 |
1997-08-14 |
Japan Tobacco Inc. |
Novel compounds and pharmaceutical use thereof
|
|
CA2257206A1
(en)
|
1996-06-07 |
1997-12-11 |
Gui-Bai Liang |
Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
|
|
AU717430B2
(en)
|
1996-08-26 |
2000-03-23 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
|
DE69729315T2
(de)
|
1996-12-16 |
2005-06-23 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazolderivate
|
|
JPH10237049A
(ja)
|
1996-12-24 |
1998-09-08 |
Nippon Chemiphar Co Ltd |
ベンズイソキサゾ−ル誘導体
|
|
EP0971588B1
(en)
|
1997-01-21 |
2004-03-17 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor modulators
|
|
KR20000070568A
(ko)
|
1997-01-28 |
2000-11-25 |
폴락 돈나 엘. |
당뇨병 및 비만 치료를 위한 β3 효능제로서의 티아졸 벤젠설폰아미드
|
|
KR100510794B1
(ko)
|
1997-02-04 |
2005-08-31 |
더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 |
살진균 카르복스아미드
|
|
BRPI9807848B8
(pt)
|
1997-02-21 |
2016-05-31 |
Bayer Schering Pharma Ag |
compostos de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos.
|
|
AU6691498A
(en)
|
1997-03-07 |
1998-09-22 |
Metabasis Therapeutics, Inc. |
Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase
|
|
WO1998039342A1
(en)
|
1997-03-07 |
1998-09-11 |
Metabasis Therapeutics, Inc. |
Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
|
US6284748B1
(en)
|
1997-03-07 |
2001-09-04 |
Metabasis Therapeutics, Inc. |
Purine inhibitors of fructose 1,6-bisphosphatase
|
|
CA2283797A1
(en)
|
1997-03-18 |
1998-09-24 |
Paul Elliot Bender |
Novel cannabinoid receptor agonists
|
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
WO1998047505A1
(en)
|
1997-04-23 |
1998-10-29 |
Banyu Pharmaceutical Co., Ltd. |
Neuropeptide y receptor antagonist
|
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
|
EP0994890B1
(en)
|
1997-06-10 |
2003-08-06 |
Glaxo Group Limited |
Benzimidazole derivatives
|
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
|
NZ502642A
(en)
|
1997-07-03 |
2002-06-28 |
Du Pont Pharm Co |
Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
|
|
AU8127998A
(en)
|
1997-07-11 |
1999-02-08 |
Japan Tobacco Inc. |
Quinoline compounds and medicinal uses thereof
|
|
CN1280574A
(zh)
|
1997-10-27 |
2001-01-17 |
雷迪研究基金会 |
新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
|
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
JP2002501909A
(ja)
|
1998-01-29 |
2002-01-22 |
ドクター・レディーズ・リサーチ・ファウンデーション |
新規なアルカン酸およびその医薬における使用、並びにその製造方法、およびそれを含有する薬学的組成物
|
|
BR9909242A
(pt)
|
1998-02-25 |
2000-11-14 |
Genetics Inst |
Inibidores de fosfolipase a2
|
|
CA2322487C
(en)
|
1998-03-06 |
2010-07-20 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
|
CA2326606A1
(en)
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
Aminoalkyl substituted 9h-pyridino[2,3-b]indole and 9h-pyrimidino[4,5-b]indole derivatives:crf1 and npy1 receptors
|
|
ATE269846T1
(de)
|
1998-04-29 |
2004-07-15 |
Ortho Mcneil Pharm Inc |
N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
|
|
JP2002507543A
(ja)
|
1998-05-27 |
2002-03-12 |
ドクター・レディーズ・リサーチ・ファウンデーション |
二環系化合物、その製造方法およびそれらを含有する薬学的組成物
|
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
CA2334551A1
(en)
|
1998-06-11 |
1999-12-16 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
CN1187337C
(zh)
|
1998-07-15 |
2005-02-02 |
帝人株式会社 |
硫代苯并咪唑衍生物
|
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
US6489476B1
(en)
|
1998-09-09 |
2002-12-03 |
Metabasis Therapeutics, Inc. |
Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase
|
|
MXPA01002461A
(es)
|
1998-09-10 |
2003-03-10 |
Millennium Pharm Inc |
Genes inducidos por leptin.
|
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
|
DE19844547C2
(de)
|
1998-09-29 |
2002-11-07 |
Aventis Pharma Gmbh |
Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1121111B1
(en)
|
1998-10-15 |
2010-02-10 |
Imperial Innovations Limited |
Compounds for the treatment of weight loss
|
|
JP2002527503A
(ja)
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物類、それらの調製及び使用
|
|
EP1123292A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
WO2000023415A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
CA2350714A1
(en)
|
1998-11-10 |
2000-05-18 |
Merck & Co., Inc. |
Spiro-indolines as y5 receptor antagonists
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
|
PT1165570E
(pt)
|
1999-03-05 |
2007-01-31 |
Metabasis Therapeutics Inc |
Novos pró-fármacos contendo fósforo
|
|
CA2367666C
(en)
|
1999-03-19 |
2008-11-25 |
Carl M. Mendel |
Method of treating eating disorders
|
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
|
EP1183245B1
(en)
|
1999-04-22 |
2007-05-09 |
H. Lundbeck A/S |
Selective npy (y5) antagonists
|
|
CA2373035A1
(en)
|
1999-05-05 |
2000-11-16 |
Scott Dax |
3a,4,5,9b-tetrahydro-1h-benz[e]indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders
|
|
ATE306481T1
(de)
|
1999-05-12 |
2005-10-15 |
Ortho Mcneil Pharm Inc |
Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
|
|
WO2000074679A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
|
JP4295458B2
(ja)
|
1999-06-30 |
2009-07-15 |
アムジェン インコーポレイテッド |
Ｐｐａｒ−ガンマ活性調節用化合物
|
|
ES2250126T3
(es)
|
1999-06-30 |
2006-04-16 |
H. Lundbeck A/S |
Antagonistas selectivos del npy(y5).
|
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
|
HUP0202143A3
(en)
|
1999-07-28 |
2003-12-29 |
Ortho Mcneil Pharm Inc |
Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use
|
|
BR0012984A
(pt)
|
1999-08-04 |
2002-07-16 |
Millennium Pharm Inc |
Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica
|
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
|
CA2383147A1
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Mch antagonists
|
|
NZ517575A
(en)
|
1999-09-30 |
2004-04-30 |
Neurogen Corp |
Certain alkylene diamine-substituted heterocycles
|
|
PL354675A1
(en)
|
1999-09-30 |
2004-02-09 |
Neurogen Corporation |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
CA2379633C
(en)
|
1999-09-30 |
2006-06-20 |
Neurogen Corporation |
Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
TWI262185B
(en)
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
|
AU7802700A
(en)
|
1999-10-06 |
2001-05-10 |
Melacure Therapeutics Ab |
Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase
|
|
CA2384378C
(en)
|
1999-10-06 |
2011-05-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
|
HK1047577B
(zh)
|
1999-10-13 |
2005-09-16 |
辉瑞产品公司 |
用作一元胺重摄取抑制剂的联芳醚衍生物
|
|
EP1230230B1
(de)
|
1999-11-05 |
2003-09-17 |
Aventis Pharma Deutschland GmbH |
Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
|
|
KR20020062342A
(ko)
|
1999-12-16 |
2002-07-25 |
쉐링 코포레이션 |
치환된 이미다졸 뉴로펩티드 ｙ ｙ5 수용체 길항제
|
|
RU2263674C2
(ru)
|
2000-01-17 |
2005-11-10 |
Тейдзин Лимитед |
Бензимидазольное производное, ингибитор человеческой химазы, терапевтический агент и фармацевтическая композиция на его основе
|
|
CA2365118A1
(en)
|
2000-01-17 |
2001-07-26 |
Teijin Limited |
Inhibitor against human chymase activity
|
|
EP1251865A1
(en)
|
2000-01-18 |
2002-10-30 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
WO2001056592A1
(en)
|
2000-02-01 |
2001-08-09 |
Novo Nordisk A/S |
Use of compounds for the regulation of food intake
|
|
CA2399791A1
(en)
|
2000-02-11 |
2001-08-16 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
|
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
|
EP1264826B1
(en)
|
2000-02-22 |
2005-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Novel imidazoline compounds
|
|
BR0108605A
(pt)
|
2000-02-23 |
2002-11-19 |
Aventis Pharma Gmbh |
Derivados de 8,8a-dihidro-indeno[1,2-d]tiazol, que na posição 8a são substituìdos; processos para a sua preparação e seu emprego como medicamentos, por exemplo, como anoréxicos
|
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
|
EE04963B1
(et)
|
2000-02-26 |
2008-02-15 |
Aventis Pharma Deutschland Gmbh |
8,8a-dihdroindeno[1,2-d]tiasooli derivaadid, mille 2-asendis on sulfoonamido- v?i sulfonorhma sisaldav asendaja, nende valmistamismeetod ja kasutamine ravimitena
|
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
KR20070087103A
(ko)
|
2000-03-14 |
2007-08-27 |
액테리온 파마슈티칼 리미티드 |
1,2,3,4-테트라하이드로이소퀴놀린 유도체
|
|
CN1205188C
(zh)
|
2000-03-23 |
2005-06-08 |
索尔瓦药物有限公司 |
具有cb1－拮抗活性的4,5－二氢－1h－吡唑衍生物
|
|
WO2001070337A1
(en)
|
2000-03-23 |
2001-09-27 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
AU2001249296B2
(en)
|
2000-03-23 |
2005-03-24 |
Merck Sharp & Dohme Corp. |
Substituted piperidines as melanocortin receptor agonists
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
EP1142886A1
(en)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinnin, a process for its production and its use as a pharmaceutical
|
|
JP2001354671A
(ja)
|
2000-04-14 |
2001-12-25 |
Nippon Chemiphar Co Ltd |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
AU2001248279A1
(en)
|
2000-04-17 |
2001-10-30 |
Novo-Nordisk A/S |
New compounds, their preparation and use
|
|
WO2001082925A1
(en)
|
2000-04-28 |
2001-11-08 |
Takeda Chemical Industries, Ltd. |
Melanin concentrating hormone antagonists
|
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
|
WO2001085173A1
(en)
|
2000-05-10 |
2001-11-15 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
|
ES2252230T3
(es)
|
2000-05-11 |
2006-05-16 |
Bristol-Myers Squibb Company |
Analogos de tetrahidroisoquinolina utiles como secretores de la hormona del crecimiento.
|
|
EP1283199A4
(en)
|
2000-05-16 |
2003-12-17 |
Takeda Chemical Industries Ltd |
MELANINE CONCENTRATING HORMONE ANTAGONISTS
|
|
JP2002371059A
(ja)
|
2000-05-16 |
2002-12-26 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
|
EP1286697A2
(en)
|
2000-05-17 |
2003-03-05 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
AU2001264977B2
(en)
|
2000-05-30 |
2005-04-14 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
|
MXPA02012447A
(es)
|
2000-06-15 |
2003-04-25 |
Schering Corp |
Antagonistas receptores de trombina.
|
|
EP1289955B1
(en)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
|
WO2002006245A1
(en)
|
2000-07-05 |
2002-01-24 |
Synaptic Pharmarceutical Corporation |
Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
|
|
MXPA03000174A
(es)
|
2000-07-06 |
2003-09-22 |
Neurogen Corp |
Ligandos de receptor de hormona concentradora de melanina.
|
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
|
KR20030033002A
(ko)
|
2000-07-24 |
2003-04-26 |
아다나 바이오싸이언스 리미티드 |
그렐린 길항제
|
|
AU2001283955B2
(en)
|
2000-07-31 |
2006-05-18 |
F. Hoffmann-La Roche Ag |
Piperazine derivatives
|
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
|
AU2001277754B2
(en)
|
2000-08-10 |
2005-09-29 |
Mitsubishi Tanabe Pharma Corporation |
Proline derivatives and use thereof as drugs
|
|
ATE542805T1
(de)
|
2000-08-11 |
2012-02-15 |
Nippon Chemiphar Co |
Ppar-delta aktivatoren
|
|
AU2001285442A1
(en)
|
2000-08-17 |
2002-02-25 |
Gliatech, Inc. |
Novel alicyclic imidazoles as H3 agents
|
|
WO2002015905A1
(en)
|
2000-08-21 |
2002-02-28 |
Gliatech, Inc. |
The use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity
|
|
AU2001288294A1
(en)
|
2000-08-21 |
2002-03-04 |
Merck And Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
|
AU2001288285B2
(en)
|
2000-08-23 |
2005-09-29 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin receptor agonists
|
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
|
US20020165223A1
(en)
|
2000-09-14 |
2002-11-07 |
Greenlee William J. |
Substituted urea neuropeptide Y Y5 receptor antagonists
|
|
WO2002026707A1
(en)
|
2000-09-26 |
2002-04-04 |
Biovitrum Ab |
Novel compounds
|
|
WO2002026743A1
(en)
|
2000-09-26 |
2002-04-04 |
Biovitrum Ab |
Novel pyridazine compounds for the treatment of diabetes
|
|
HRP20030288B1
(en)
|
2000-10-13 |
2005-02-28 |
Eli Lilly And Company |
Growth hormone secretagogues
|
|
JP4047723B2
(ja)
|
2000-10-16 |
2008-02-13 |
エフ．ホフマン−ラ ロシュ アーゲー |
インドリン誘導体、および５−ｈｔ２受容体リガンドとしてのその使用
|
|
MXPA03003455A
(es)
|
2000-10-20 |
2003-07-14 |
Pfizer Prod Inc |
Agonistas del receptor beta3-adrenergico y usos de los mismos.
|
|
JP4734705B2
(ja)
|
2000-10-31 |
2011-07-27 |
三菱化学株式会社 |
リチウム二次電池用正極材料、リチウム二次電池用正極及びリチウム二次電池
|
|
WO2002036596A2
(en)
|
2000-11-03 |
2002-05-10 |
Wyeth |
CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
|
|
US6825220B2
(en)
|
2000-11-10 |
2004-11-30 |
Eli Lilly And Company |
3-Substituted oxindole β 3 agonists
|
|
WO2002040019A1
(en)
|
2000-11-15 |
2002-05-23 |
Banyu Pharmaceutical Co.,Ltd. |
Benzimidazole derivatives
|
|
CN1227237C
(zh)
|
2000-11-20 |
2005-11-16 |
比奥维特罗姆股份公司 |
作为五羟色胺5－ht2受体拮抗剂的哌嗪基吡嗪化合物
|
|
CA2448729A1
(en)
|
2000-11-20 |
2002-05-23 |
Biovitrum Ab |
Piperazinyl and piperidyl substituted heterocyclic compounds
|
|
EP1353918B1
(en)
|
2000-11-28 |
2005-01-12 |
Smithkline Beecham Plc |
Morpholine derivatives as antagonists of orexin receptors
|
|
JPWO2002046176A1
(ja)
|
2000-12-05 |
2004-04-08 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体の活性化剤
|
|
JPWO2002046154A1
(ja)
|
2000-12-05 |
2004-04-08 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
US6566367B2
(en)
|
2000-12-12 |
2003-05-20 |
Pfizer Inc. |
Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines
|
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
|
MXPA03005745A
(es)
|
2000-12-21 |
2003-09-05 |
Schering Corp |
Neuropeptidos heteroarilo urea y antagonista de los receptores y5 del neuropeptido y.
|
|
US20040067999A1
(en)
|
2000-12-22 |
2004-04-08 |
Block Michael Howard |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
|
US6472394B1
(en)
|
2000-12-22 |
2002-10-29 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
|
US6610685B2
(en)
|
2000-12-27 |
2003-08-26 |
Hoffmann-La Roche Inc. |
Fused indole derivatives
|
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
|
ES2246390T3
(es)
|
2001-01-23 |
2006-02-16 |
Eli Lilly And Company |
Derivados de piperazina como agonistas del receptor de melanocortina.
|
|
JP2004524297A
(ja)
|
2001-01-23 |
2004-08-12 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニスト
|
|
WO2002059107A1
(en)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
IL157179A0
(en)
|
2001-02-02 |
2004-02-08 |
Takeda Chemical Industries Ltd |
Fused heterocyclic compounds
|
|
EP1363914A1
(en)
|
2001-02-05 |
2003-11-26 |
Dr. Reddy's Laboratories Ltd. |
Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
|
|
WO2002062766A2
(en)
|
2001-02-07 |
2002-08-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US20020119958A1
(en)
|
2001-02-13 |
2002-08-29 |
Shinichiro Tojo |
Therapeutic agent for hyperlipidemia
|
|
AU2002248494A1
(en)
|
2001-02-24 |
2002-09-12 |
Matthias A. Blumrich |
Global interrupt and barrier networks
|
|
JP4323169B2
(ja)
|
2001-02-28 |
2009-09-02 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−４受容体作働薬としてのアシル化ピペリジン誘導体
|
|
EP1385506B1
(en)
|
2001-02-28 |
2009-05-06 |
Merck & Co., Inc. |
Acylated piperidine derivates as melanocortin-4 receptor agonists
|
|
CN1633297A
(zh)
|
2001-02-28 |
2005-06-29 |
麦克公司 |
作为黑皮质素－4受体激动剂的酰化哌啶衍生物
|
|
GB0105772D0
(en)
|
2001-03-08 |
2001-04-25 |
Sterix Ltd |
Use
|
|
US7034056B2
(en)
|
2001-03-21 |
2006-04-25 |
Pharmacopeia Drug Discovery, Inc. |
Aryl and biaryl compounds having MCH modulatory activity
|
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
|
IL153508A
(en)
|
2001-03-22 |
2008-07-08 |
Solvay Pharm Bv |
Derivatives of 4,5 - Dihydro-1H-pyrazole with antagonistic activity to the 1CB receptor
|
|
WO2002076957A1
(en)
|
2001-03-23 |
2002-10-03 |
Nippon Chemiphar Co.,Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
EP1379242B1
(en)
|
2001-03-26 |
2012-08-15 |
Newsouth Innovations Pty Limited |
Method for treatment of cancer and compositions for use therein
|
|
US7253178B2
(en)
|
2001-03-28 |
2007-08-07 |
Eisai Co., Ltd. |
Carboxylic acids
|
|
AU782148B2
(en)
|
2001-03-29 |
2005-07-07 |
Molecular Design International, Inc. |
Beta3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
|
|
WO2002081428A1
(en)
|
2001-03-30 |
2002-10-17 |
Eisai Co., Ltd. |
Benzene compound and salt thereof
|
|
GB0108631D0
(en)
|
2001-04-05 |
2001-05-30 |
Melacure Therapeutics Ab |
Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
PE20021081A1
(es)
|
2001-04-12 |
2002-12-18 |
Pharmacopeia Drug Discovery |
Aril y biaril piperidinas con actividad moduladora mch
|
|
EP1435955A2
(en)
|
2001-05-05 |
2004-07-14 |
SmithKline Beecham P.L.C. |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
MXPA03010129A
(es)
|
2001-05-05 |
2004-03-10 |
Smithkline Beecham Plc |
N-aroilaminas-ciclicas.
|
|
US7030150B2
(en)
|
2001-05-11 |
2006-04-18 |
Trimeris, Inc. |
Benzimidazole compounds and antiviral uses thereof
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
AU2002338896B2
(en)
|
2001-05-21 |
2006-04-27 |
F.Hoffman-La Roche Ag |
Quinoline derivatives as ligands for the neuropeptide Y receptor
|
|
US6548538B2
(en)
|
2001-05-22 |
2003-04-15 |
Bayer Aktiengesellschaft |
Propionic acid derivatives
|
|
EP1389189A2
(en)
|
2001-05-22 |
2004-02-18 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
|
|
WO2002100833A1
(en)
|
2001-06-12 |
2002-12-19 |
Sumitomo Pharmaceuticals Company, Limited |
Rho KINASE INHIBITORS
|
|
WO2003000181A2
(en)
|
2001-06-20 |
2003-01-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
WO2003000685A1
(fr)
|
2001-06-20 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Derives heterocycliques a 5 chainons
|
|
US7098239B2
(en)
|
2001-06-20 |
2006-08-29 |
Merck & Co., Inc |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
EP1405636A4
(en)
|
2001-06-26 |
2009-04-15 |
Takeda Pharmaceutical |
FUNCTIONAL REGULATOR FOR RETINOID RELATIVE RECEPTOR
|
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
|
ATE370943T1
(de)
|
2001-06-27 |
2007-09-15 |
Smithkline Beecham Corp |
Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
|
|
CN1990469A
(zh)
|
2001-06-27 |
2007-07-04 |
史密丝克莱恩比彻姆公司 |
作为二肽酶抑制剂的氟代吡咯烷
|
|
AU2002316437A1
(en)
|
2001-06-27 |
2003-03-03 |
Smithkline Beecham Corporation |
Pyrrolidines as dipeptidyl peptidase inhibitors
|
|
WO2003002593A2
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
|
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
|
DE60206174T2
(de)
|
2001-06-29 |
2006-06-22 |
Novo Nordisk A/S |
Verfahren zur hemmung von tyrosinphosphatase 1b und/oder t-zellenprotein-tyrosinphosphatase und/oder anderen ptpasen mit einem asp-rest in position 48
|
|
US6688713B2
(en)
|
2001-07-02 |
2004-02-10 |
Mitsubishi Digital Electronics America, Inc. |
Television base casting
|
|
DE60225556D1
(de)
|
2001-07-03 |
2008-04-24 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
|
JP3532537B2
(ja)
|
2001-07-05 |
2004-05-31 |
株式会社テムコジャパン |
骨伝導ヘッドセット
|
|
EA005934B1
(ru)
|
2001-07-05 |
2005-08-25 |
Х. Лундбекк А/С |
Замещённые анилиновые пиперидины в качестве селективных антагонистов мсн
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
ITMI20011483A1
(it)
|
2001-07-11 |
2003-01-11 |
Res & Innovation Soc Coop A R |
Uso di composti come antagonisti funzionali ai recettori centrali deicannabinoidi
|
|
WO2003006604A2
(en)
|
2001-07-12 |
2003-01-23 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
|
WO2003007990A1
(en)
|
2001-07-18 |
2003-01-30 |
Sumitomo Pharmaceuticals Company, Limited |
Myosin agonist
|
|
JP4336196B2
(ja)
|
2001-07-18 |
2009-09-30 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作動薬としての架橋ピペリジン誘導体
|
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
TWI300064B
(en)
|
2001-07-26 |
2008-08-21 |
Schering Corp |
New neuropeptide y y5 receptor antagonists
|
|
WO2003011267A1
(fr)
|
2001-07-31 |
2003-02-13 |
The Nisshin Oillio, Ltd. |
Medicaments anti-obesite et ses substances
|
|
GB0119172D0
(en)
|
2001-08-06 |
2001-09-26 |
Melacure Therapeutics Ab |
Phenyl pyrrole derivatives
|
|
WO2003014113A1
(en)
|
2001-08-06 |
2003-02-20 |
Glenmark Pharmaceuticals Limited |
Novel benzopyran compounds and process for their preparation and use
|
|
AU2002323787B2
(en)
|
2001-08-07 |
2008-04-24 |
Banyu Pharmaceutical Co., Ltd. |
Spiro compounds
|
|
WO2003013574A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co., Inc. |
Melanin-concentrating hormone antagonists
|
|
CN1330641C
(zh)
|
2001-08-10 |
2007-08-08 |
日本化学医药株式会社 |
过氧化物酶体增殖剂响应受体δ活化剂
|
|
ATE340794T1
(de)
|
2001-08-14 |
2006-10-15 |
Lilly Co Eli |
Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
|
|
JP2005507872A
(ja)
|
2001-08-14 |
2005-03-24 |
イーライ・リリー・アンド・カンパニー |
３−置換オキシインドールβ３アゴニスト
|
|
WO2003016265A1
(en)
|
2001-08-17 |
2003-02-27 |
Eisai Co., Ltd. |
Cyclic compound and ppar agonist
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US20030092041A1
(en)
|
2001-08-23 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disorders
|
|
CA2442761A1
(en)
|
2001-08-24 |
2003-03-06 |
Teijin Limited |
Drugs comprising chymase inhibitors and ace inhibitors as effective ingredients
|
|
EP1421077A4
(en)
|
2001-08-31 |
2004-11-17 |
Univ Connecticut |
NEW PYRAZOLANALOGS ON CANNABINOID RECEPTORS
|
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
US6915444B2
(en)
|
2001-09-12 |
2005-07-05 |
Rockwell Automation Technologies, Inc. |
Network independent safety protocol for industrial controller using data manipulation techniques
|
|
CA2460578A1
(en)
|
2001-09-13 |
2003-03-27 |
Nisshin Pharma Inc. |
Propanolamine derivative having 1,4-benzodioxane ring
|
|
FR2829765A1
(fr)
*
|
2001-09-14 |
2003-03-21 |
Lipha |
Derives imidazolylalkoxylarylalcanoiques leurs applications en therapeutique
|
|
CA2459454A1
(en)
|
2001-09-14 |
2003-03-27 |
Bayer Pharmaceuticals Corporation |
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
|
|
JP2005508907A
(ja)
|
2001-09-14 |
2005-04-07 |
ノボ ノルディスク アクティーゼルスカブ |
ヒスタミンｈ３受容体に選択的に結合する置換されたピペリジン
|
|
EP1430027B1
(en)
|
2001-09-14 |
2010-09-01 |
High Point Pharmaceuticals, LLC |
Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
|
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
|
WO2003024395A2
(en)
|
2001-09-14 |
2003-03-27 |
Tularik Inc. |
Linked biaryl compounds
|
|
WO2003024965A2
(en)
|
2001-09-19 |
2003-03-27 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
|
WO2003024447A1
(en)
|
2001-09-20 |
2003-03-27 |
Smithkline Beecham Corporation |
Inhibitors of glycogen synthase kinase-3
|
|
AU2002333853B2
(en)
|
2001-09-21 |
2006-07-13 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
|
|
TWI231757B
(en)
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
|
ES2272809T3
(es)
|
2001-09-21 |
2007-05-01 |
Solvay Pharm Bv |
Nuevos derivados de 4,5-dihidro-1h-pirazol con actividad antagonista de cb1.
|
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
|
EP1432679A1
(en)
|
2001-09-24 |
2004-06-30 |
Bayer Pharmaceuticals Corporation |
Preparation and use of pyrrole derivatives for treating obesity
|
|
PE20030547A1
(es)
|
2001-09-24 |
2003-08-18 |
Bayer Corp |
Derivados de imidazol para el tratamiento de la obesidad
|
|
AU2002331898A1
(en)
|
2001-09-24 |
2003-04-07 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Induction of brown adipocytes by transcription factor nfe2l2
|
|
ES2320979T3
(es)
|
2001-09-24 |
2009-06-01 |
Imperial Innovations Limited |
Pyy-36 para la reduccion o prevencion de la obesidad.
|
|
MXPA04002249A
(es)
|
2001-09-24 |
2004-06-29 |
Bayer Pharmaceuticals Corp |
Preparacion y uso de derivados de 1,5,6,7,-tetrahidro-pirrolo[3,2-c]piridina para el tratamiento de la obesidad.
|
|
HRP20040309A2
(en)
|
2001-09-26 |
2006-05-31 |
Bayer Pharmaceuticals Corporation |
1,6-nafthyridine derivatives as antidiabetics
|
|
US6787558B2
(en)
|
2001-09-28 |
2004-09-07 |
Hoffmann-La Roche Inc. |
Quinoline derivatives
|
|
EP1432693A2
(en)
|
2001-10-01 |
2004-06-30 |
Taisho Pharmaceutical Co. Ltd. |
Mch receptor antagonists
|
|
US7119110B2
(en)
|
2001-10-05 |
2006-10-10 |
Interhealth Nutraceuticals Incorporated |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
|
|
WO2003031408A2
(en)
|
2001-10-08 |
2003-04-17 |
Eli Lilly And Company |
Tricyclic compounds useful for modulating lxr
|
|
JP2005506338A
(ja)
|
2001-10-09 |
2005-03-03 |
ニューロクライン バイオサイエンシーズ， インコーポレイテッド |
メラノコルチンレセプターのリガンドならびに関連の配合物および方法
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
|
PT1445258E
(pt)
|
2001-10-12 |
2009-07-02 |
Nippon Chemiphar Co |
Activador para o receptor delta activado por proliferador de peroxissoma
|
|
ES2256560T3
(es)
|
2001-10-12 |
2006-07-16 |
Bayer Pharmaceuticals Corporation |
Heterociclos de 5 mienbros que contienen nitrogeno sustituidos con felino para el tratamiento de la obesidad.
|
|
US6573396B2
(en)
|
2001-10-12 |
2003-06-03 |
Exxonmobil Chemical Patents Inc. |
Co-production of dialkyl carbonates and diols with treatment of hydroxy alkyl carbonate
|
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
IL161429A0
(en)
|
2001-10-16 |
2004-09-27 |
Reddys Lab Ltd Dr |
Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same
|
|
RU2004114875A
(ru)
|
2001-10-17 |
2005-09-10 |
Ново Нордиск А/С (DK) |
Производные дикарбоновых кислот, их получение и терапевтическое применение
|
|
DE10151390A1
(de)
|
2001-10-18 |
2003-05-08 |
Bayer Ag |
Essigsäurederivate
|
|
IL161478A0
(en)
|
2001-10-25 |
2004-09-27 |
Takeda Chemical Industries Ltd |
Quinoline compound
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
US20050054696A1
(en)
|
2001-10-29 |
2005-03-10 |
Takeshi Nakamura |
Indole compounds and medicinal use thereof
|
|
US7342117B2
(en)
|
2001-10-30 |
2008-03-11 |
Astellas Pharma Inc. |
α-form or β-form crystal of acetanilide derivative
|
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
|
EA010859B1
(ru)
|
2001-11-01 |
2008-12-30 |
Янссен Фармацевтика Н.В. |
Гетероариламины - производные пиримидина и пиридазина в качестве ингибиторов гликогенсинтаза-киназы 3-бета (ингибиторов gsk3)
|
|
NZ531855A
(en)
|
2001-11-01 |
2005-12-23 |
Janssen Pharmaceutica Nv |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
|
KR20040053210A
(ko)
|
2001-11-02 |
2004-06-23 |
화이자 프로덕츠 인크. |
Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
|
|
HN2002000317A
(es)
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
US6673815B2
(en)
|
2001-11-06 |
2004-01-06 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
US7163952B2
(en)
|
2001-12-03 |
2007-01-16 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
|
US20030171411A1
(en)
|
2001-12-21 |
2003-09-11 |
Kodra Janos Tibor |
Amide derivatives as therapeutic agents
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
CN101050215A
(zh)
|
2001-12-28 |
2007-10-10 |
阿卡蒂亚药品公司 |
作为单胺受体调节剂的螺氮杂环化合物
|
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
|
CA2474702A1
(en)
|
2002-01-30 |
2003-08-07 |
Tularik Inc |
Heterocyclic arylsulfonamidobenzylic compounds
|
|
US7514452B2
(en)
|
2002-02-01 |
2009-04-07 |
Dainippon Pharmaceutical Co., Ltd |
2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
|
|
AU2003217274A1
(en)
|
2002-02-25 |
2003-09-09 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
WO2003072532A1
(en)
|
2002-02-28 |
2003-09-04 |
Japan Tobacco Inc. |
Ester compound and medicinal use thereof
|
|
WO2003077847A2
(en)
|
2002-03-12 |
2003-09-25 |
Merck & Co., Inc. |
Substituted amides
|
|
AU2003222278A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Schering Aktiengesellschaft |
Menthol substituted antithrombotic pai-1 inhibitors
|
|
WO2003091213A1
(en)
|
2002-04-25 |
2003-11-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel amide derivatives or salts thereof
|
|
AU2003231388A1
(en)
|
2002-04-25 |
2003-11-10 |
Sumitomo Pharmaceuticals Co., Ltd. |
Novel piperidine derivative
|
|
JP2005534632A
(ja)
|
2002-05-10 |
2005-11-17 |
ニューロクライン バイオサイエンセズ， インコーポレイテッド |
メラノコルチンレセプターリガンドとしての置換ピペラジン
|
|
DE10222034A1
(de)
|
2002-05-17 |
2003-11-27 |
Bayer Ag |
Tetrahydroisochinolin-Derivate
|
|
AU2003241173A1
(en)
|
2002-05-24 |
2003-12-12 |
Takeda Pharmaceutical Company Limited |
1,2-azole derivatives with hypoglycemic and hypolipidemic activity
|
|
EP1551860B1
(en)
|
2002-06-19 |
2006-11-22 |
Karo Bio Ab |
Glucocorticoid receptor ligands for the treatment of metabolic disorders
|
|
DE10229777A1
(de)
|
2002-07-03 |
2004-01-29 |
Bayer Ag |
Indolin-Phenylsulfonamid-Derivate
|
|
GB0215579D0
(en)
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
|
EP1523292B1
(en)
|
2002-07-08 |
2018-05-16 |
Coloplast A/S |
Conduit device
|
|
SE0202134D0
(sv)
|
2002-07-08 |
2002-07-08 |
Astrazeneca Ab |
Therapeutic agents
|
|
MXPA04002269A
(es)
|
2002-07-09 |
2004-06-29 |
Actelion Pharmaceuticals Ltd |
Derivados de 7,8,9,10-tetrahidro-6h-azepino,6,7,8,9-tetrahidro-pirido y 2,3-dihidro-2h-pirrolo[2,1-b]-quinazolinona.
|
|
JPWO2004007439A1
(ja)
|
2002-07-10 |
2005-11-10 |
住友製薬株式会社 |
ビアリール誘導体
|
|
US20060160700A1
(en)
|
2002-07-18 |
2006-07-20 |
Basf Aktiengesellschaft |
Nadh-dependent cytochrome b5 reductase as target for herbicides
|
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US20050272036A1
(en)
|
2002-07-27 |
2005-12-08 |
Barton Peter J |
Ketones
|
|
CA2493313C
(en)
|
2002-07-29 |
2010-03-09 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
|
JP2004067629A
(ja)
|
2002-08-09 |
2004-03-04 |
Yamanouchi Pharmaceut Co Ltd |
ミトコンドリア機能活性化剤及び新規なベンゾイミダゾール誘導体
|
|
DE10238860A1
(de)
|
2002-08-24 |
2004-03-04 |
Bayerische Motoren Werke Ag |
Brennstoff-Zelle mit einer das Brenngas über der Elektroden-Oberfläche verteilenden perforierten Folie
|
|
US6849761B2
(en)
|
2002-09-05 |
2005-02-01 |
Wyeth |
Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia
|
|
WO2004022551A1
(ja)
|
2002-09-06 |
2004-03-18 |
Takeda Pharmaceutical Company Limited |
フランまたはチオフェン誘導体およびその医薬用途
|
|
WO2004022004A2
(en)
|
2002-09-06 |
2004-03-18 |
Bayer Pharmaceuticals Corporation |
Modified glp-1 receptor agonists and their pharmacological methods of use
|
|
ES2273083T3
(es)
|
2002-09-18 |
2007-05-01 |
Glaxo Group Limited |
N-aroilaminas ciclicas como antagonistas de los receptores de orexina.
|
|
US20040138258A1
(en)
|
2002-09-18 |
2004-07-15 |
Hanauske-Abel Hartmut M. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase and uses therefor
|
|
US7045527B2
(en)
|
2002-09-24 |
2006-05-16 |
Amgen Inc. |
Piperidine derivatives
|
|
US20060183789A1
(en)
|
2002-09-25 |
2006-08-17 |
Lavanya Rajachandran |
Methods for preventing and treating obesity in patients with mc4 receptor mutations
|
|
NZ539013A
(en)
|
2002-10-03 |
2007-05-31 |
Novartis Ag |
Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
|
|
EP1554874A1
(en)
|
2002-10-11 |
2005-07-20 |
Koninklijke Philips Electronics N.V. |
A unit for and method of image conversion
|
|
US20050256159A1
(en)
|
2002-10-11 |
2005-11-17 |
Astrazeneca Ab |
1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
|
|
US7291594B2
(en)
|
2002-10-11 |
2007-11-06 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
GLP-1 derivative and preparation thereof absorbable via mucous membrane
|
|
CA2502356A1
(en)
|
2002-10-15 |
2004-04-29 |
Synta Pharmaceuticals Corp. |
Aromatic bicyclic heterocyles to modulate 1l - 12 production
|
|
CA2501228A1
(en)
|
2002-10-24 |
2004-05-06 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
|
AU2003286776A1
(en)
|
2002-10-30 |
2004-06-07 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
|
US6852748B1
(en)
|
2002-10-30 |
2005-02-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
|
|
DE10250743A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
FR2846656B1
(fr)
|
2002-11-05 |
2004-12-24 |
Servier Lab |
Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
GB0225944D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1562574A1
(en)
|
2002-11-07 |
2005-08-17 |
Astrazeneca AB |
2-oxo-ethanesulfonamide derivates
|
|
GB0225986D0
(en)
|
2002-11-07 |
2002-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
US7960369B2
(en)
|
2002-11-08 |
2011-06-14 |
Takeda Pharmaceutical Company Limited |
Receptor function regulator
|
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2004043913A2
(en)
|
2002-11-08 |
2004-05-27 |
Trimeris, Inc. |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
US20050143449A1
(en)
|
2002-11-15 |
2005-06-30 |
The Salk Institute For Biological Studies |
Non-steroidal farnesoid X receptor modulators and methods for the use thereof
|
|
MXPA05005260A
(es)
|
2002-11-18 |
2005-07-25 |
Pfizer Prod Inc |
Amidas ciclicas fluoradas que inhiben la dipeptidil peptidasa iv.
|
|
GB0226931D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0226930D0
(en)
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2506843A1
(en)
|
2002-11-22 |
2004-06-10 |
Novo-Nordisk A/S |
2,5-diketopiperazines for the treatment of obesity
|
|
AU2003295842A1
(en)
|
2002-11-25 |
2004-06-18 |
Gni Ltd. |
Inferring gene regulatory networks from time-ordered gene expression data using differential equations
|
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
DE60329030D1
(de)
|
2002-12-04 |
2009-10-08 |
Ore Pharmaceuticals Inc |
Melanocortin-rezeptormodulatoren
|
|
US7132456B2
(en)
|
2002-12-11 |
2006-11-07 |
Eli Lilly And Company |
MCH receptor antagonists
|
|
JP2004196702A
(ja)
|
2002-12-18 |
2004-07-15 |
Yamanouchi Pharmaceut Co Ltd |
新規なアミド誘導体又はその塩
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
US20040209928A1
(en)
|
2002-12-30 |
2004-10-21 |
Ravi Kurukulasuriya |
Glucagon receptor antagonists/inverse agonists
|
|
JP4716734B2
(ja)
|
2003-01-06 |
2011-07-06 |
イーライ リリー アンド カンパニー |
グルコキナーゼ活性化物質としての置換されたアリールシクロプロピルアセトアミド
|
|
WO2004063194A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Heteroaryl compounds
|
|
DE10301788B4
(de)
|
2003-01-20 |
2005-08-25 |
Aventis Pharma Deutschland Gmbh |
Pharmazeutische Verwendung von Pyrimido[5,4-e][1,2,4]triazin-5,7-dionen
|
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
KR100998796B1
(ko)
|
2003-01-31 |
2010-12-06 |
가부시키가이샤산와카가쿠켄큐쇼 |
디펩티딜 펩티다아제 ｉｖ를 저해하는 화합물
|
|
US6759546B1
(en)
|
2003-02-04 |
2004-07-06 |
Allergan, Inc. |
3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity
|
|
WO2004072041A1
(en)
|
2003-02-12 |
2004-08-26 |
Care X S.A. |
Tetrahydroquinolines as agonists of liver- x receptors
|
|
CA2514363A1
(en)
|
2003-02-12 |
2004-08-26 |
Transtech Pharma, Inc. |
Substituted azole derivatives as therapeutic agents
|
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
|
US20040167183A1
(en)
|
2003-02-20 |
2004-08-26 |
The Procter & Gamble Company |
Phenethylamino sulfamic acids
|
|
FR2851563B1
(fr)
|
2003-02-26 |
2005-04-22 |
Sod Conseils Rech Applic |
Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
|
|
US20040224992A1
(en)
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EP1460069A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
|
|
CL2004000553A1
(es)
|
2003-03-20 |
2005-02-04 |
Actelion Pharmaceuticals Ltd |
Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
|
|
EP1468999A1
(en)
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
MXPA05010137A
(es)
|
2003-03-26 |
2005-11-16 |
Actelion Pharmaceuticals Ltd |
Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
|
|
JP2004315511A
(ja)
|
2003-03-31 |
2004-11-11 |
Taisho Pharmaceut Co Ltd |
Ｍｃｈ受容体アンタゴニスト
|
|
CN100475793C
(zh)
|
2003-03-31 |
2009-04-08 |
大正制药株式会社 |
喹唑啉衍生物及其制备药物的用途
|
|
FR2852957B1
(fr)
|
2003-03-31 |
2005-06-10 |
Sod Conseils Rech Applic |
Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament
|
|
US20040199842A1
(en)
|
2003-04-04 |
2004-10-07 |
Sartschev Ronald A. |
Test system with high accuracy time measurement system
|
|
US20070027073A1
(en)
|
2003-04-08 |
2007-02-01 |
Menachem Rubinstein |
Long-acting derivatives of pyy agonists
|
|
WO2004089918A1
(ja)
|
2003-04-09 |
2004-10-21 |
Japan Tobacco Inc. |
複素芳香５員環化合物及びその医薬用途
|
|
GB0308335D0
(en)
|
2003-04-10 |
2003-05-14 |
Novartis Ag |
Organic compounds
|
|
EP1615667A2
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
Combinations of an 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist
|
|
BRPI0409447A
(pt)
|
2003-04-14 |
2006-04-18 |
Inst For Pharm Discovery Inc |
ácidos fenilalcanóicos substituìdos
|
|
WO2004092158A1
(en)
|
2003-04-17 |
2004-10-28 |
Pfizer Products Inc. |
Carboxamide derivatives as anti-diabetic agents
|
|
MXPA05011702A
(es)
|
2003-04-30 |
2006-01-23 |
Pfizer Prod Inc |
Agentes antidiabeticos.
|
|
BRPI0409938A
(pt)
|
2003-05-01 |
2006-04-25 |
Vernalis Res Ltd |
derivados de azetidinacarboxamida e seu uso em terapia
|
|
AU2003902260A0
(en)
|
2003-05-09 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
US7119205B2
(en)
|
2003-05-16 |
2006-10-10 |
Abbott Laboratories |
Thienopyridones as AMPK activators for the treatment of diabetes and obesity
|
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
WO2004108674A1
(ja)
|
2003-06-05 |
2004-12-16 |
Kissei Pharmaceutical Co., Ltd. |
アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途
|
|
CN1802351A
(zh)
|
2003-06-11 |
2006-07-12 |
麦克公司 |
被取代的3－烷基和3－链烯基氮杂环丁烷衍生物
|
|
JP2006527212A
(ja)
|
2003-06-12 |
2006-11-30 |
ノボ ノルディスク アクティーゼルスカブ |
ホルモン感受性リパーゼの阻害剤として使用するための、置換ピペラジンカルバメート
|
|
GB0314057D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
JP2006527770A
(ja)
|
2003-06-18 |
2006-12-07 |
アストラゼネカ アクチボラグ |
Ｃｂ１モジュレーターとしての２−置換５，６−ジアリール−ピラジン誘導体
|
|
GB0314049D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
US20070105759A1
(en)
|
2003-06-19 |
2007-05-10 |
Eli Lilly And Company |
Melanocortin receptor 4 (mc4) agonists and their uses
|
|
GB0314261D0
(en)
|
2003-06-19 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
KR100809201B1
(ko)
|
2003-06-20 |
2008-02-29 |
에프. 호프만-라 로슈 아게 |
카나바노이드 수용체 1 역작용제로서 2-아미노벤조티아졸
|
|
US7355049B2
(en)
|
2003-06-24 |
2008-04-08 |
Hoffmann-La Roche Inc. |
Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
|
|
GB0314967D0
(en)
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
CA2530111A1
(en)
|
2003-06-27 |
2005-01-06 |
Tel-Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
|
AU2004253543B2
(en)
|
2003-07-01 |
2009-02-19 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
CA2532397A1
(en)
|
2003-07-21 |
2005-02-03 |
Smithkline Beecham Corporation |
(2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
|
|
JP2005042839A
(ja)
|
2003-07-23 |
2005-02-17 |
Iseki & Co Ltd |
作業車両の変速制御装置
|
|
US7872014B2
(en)
|
2003-07-23 |
2011-01-18 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
DK1648922T3
(da)
|
2003-07-31 |
2011-03-14 |
Tranzyme Pharma Inc |
Rumligt definerede makrocykliske forbindelser, der er anvendelige til opdagelse af lægemidler
|
|
GB0318464D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
|
US20070161582A1
(en)
|
2003-08-08 |
2007-07-12 |
Dusan Mijikovic |
Pharmaceutical compositions and methods for metabolic modulation
|
|
KR20060037435A
(ko)
|
2003-08-12 |
2006-05-03 |
에프. 호프만-라 로슈 아게 |
2-아미노-5-벤조일싸이아졸 ｎｐｙ 길항물질
|
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
|
US20050148643A1
(en)
|
2003-08-19 |
2005-07-07 |
Agouron Pharmaceuticals, Inc. |
Carbamate compositions and methods fo rmodulating the activity of the CHK1 enzyme
|
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
|
JP4387360B2
(ja)
|
2003-08-22 |
2009-12-16 |
帝人ファーマ株式会社 |
キマーゼ阻害剤を有効成分として含有する薬剤
|
|
TWI290140B
(en)
|
2003-08-25 |
2007-11-21 |
Schering Corp |
2-Substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for thr treatment of obesity and related disorders
|
|
PE20050347A1
(es)
|
2003-08-26 |
2005-05-04 |
Teijin Pharma Ltd |
Derivados de pirrolopirimidina
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
|
ES2326980T3
(es)
*
|
2003-10-02 |
2009-10-22 |
Schering Corporation |
Aminobenzimidazoles utiles como antagonistas selectivos del receptor de la hormona concentrada de melamina (mch) para el tratamiento de la obesidad y desordenes asociados.
|
|
US20050107374A1
(en)
|
2003-10-21 |
2005-05-19 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
US7714009B2
(en)
|
2003-10-31 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing fused heterocyclic compounds
|
|
EP1692113B1
(en)
|
2003-11-14 |
2017-09-27 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
JP2007512359A
(ja)
|
2003-11-19 |
2007-05-17 |
メタバシス・セラピューティクス・インコーポレイテッド |
新規なリン含有甲状腺ホルモン様物質
|
|
TW200522944A
(en)
|
2003-12-23 |
2005-07-16 |
Lilly Co Eli |
CB1 modulator compounds
|
|
EP1730118A1
(en)
|
2004-02-12 |
2006-12-13 |
Transtech Pharma, Inc. |
Substituted azole derivatives, compositions, and methods of use
|
|
BRPI0507629A
(pt)
|
2004-02-13 |
2007-07-03 |
Banyu Pharma Co Ltd |
composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
|
|
US7393847B2
(en)
*
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
|
CN1942428A
(zh)
|
2004-04-13 |
2007-04-04 |
默克公司 |
Cetp抑制剂
|
|
US7097961B2
(en)
|
2004-05-17 |
2006-08-29 |
Agfa Gevaert |
Stabilizers for use in substantially light-insensitive thermographic recording materials
|
|
JP2008501714A
(ja)
|
2004-06-04 |
2008-01-24 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
DE102004028862A1
(de)
*
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
US7732479B2
(en)
|
2004-08-19 |
2010-06-08 |
Tel Aviv University Future Technology Development L.P. |
Compositions for treating amyloid associated diseases
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038738A1
(ja)
*
|
2004-10-08 |
2006-04-13 |
Takeda Pharmaceutical Company Limited |
受容体機能調節剤
|
|
JP2008518988A
(ja)
|
2004-11-02 |
2008-06-05 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
Ｕｖ−日焼け止め調製物のための添加剤
|
|
US8003806B2
(en)
|
2004-11-12 |
2011-08-23 |
OSI Pharmaceuticals, LLC |
Integrin antagonists useful as anticancer agents
|
|
CA2589828C
(en)
|
2004-12-06 |
2014-07-08 |
Newsouth Innovations Pty Limited |
Compositions comprising a taxoid and a benzimidazole carbamate for the treatment of cancer
|
|
US7429608B2
(en)
|
2005-01-20 |
2008-09-30 |
Amgen Inc. |
Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
|
|
WO2006094209A2
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
N-benzimidazolylalkyl-substituted amide sirtuin modulators
|
|
US20060223849A1
(en)
|
2005-03-14 |
2006-10-05 |
Mjalli Adnan M |
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
|
|
TWI370820B
(en)
|
2005-04-27 |
2012-08-21 |
Takeda Pharmaceutical |
Fused heterocyclic compounds
|
|
AU2006250354A1
(en)
|
2005-05-23 |
2006-11-30 |
Japan Tobacco Inc. |
Pyrazole compound and therapeutic agent for diabetes comprising the same
|
|
CA2608687A1
(en)
|
2005-05-25 |
2006-11-30 |
Actelion Pharmaceuticals Ltd. |
New antibiotic derivatives
|
|
JP2009500351A
(ja)
|
2005-07-04 |
2009-01-08 |
ドクター レディズ ラボラトリーズ リミテッド |
Ａｍｐｋアクチベータとしてのチアゾール誘導体
|
|
JPWO2007007463A1
(ja)
|
2005-07-11 |
2009-01-29 |
出光興産株式会社 |
電子吸引性置換基を有する含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
|
KR20080028424A
(ko)
|
2005-07-11 |
2008-03-31 |
이데미쓰 고산 가부시키가이샤 |
질소 함유 헤테로환 유도체 및 그것을 사용한 유기전기발광 소자
|
|
JP2007039406A
(ja)
|
2005-08-05 |
2007-02-15 |
Idemitsu Kosan Co Ltd |
含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
|
JP2007153778A
(ja)
|
2005-12-02 |
2007-06-21 |
Idemitsu Kosan Co Ltd |
含窒素複素環誘導体及びそれを用いた有機エレクトロルミネッセンス素子
|
|
JP2009525955A
(ja)
|
2006-01-13 |
2009-07-16 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
EP2295432A1
(en)
|
2006-02-10 |
2011-03-16 |
TransTech Pharma Inc. |
Process for the preparation of aminobenzimidazole derivatives
|
|
KR101472248B1
(ko)
|
2006-02-10 |
2014-12-16 |
서미트 코포레이션 피엘씨 |
뒤시엔느 근이영양증의 치료
|
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
WO2008008551A2
(en)
|
2006-07-14 |
2008-01-17 |
Merck & Co., Inc. |
2-substituted proline bis-amide orexin receptor antagonists
|
|
EP1878724A1
(en)
|
2006-07-15 |
2008-01-16 |
sanofi-aventis |
A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
KR20090083382A
(ko)
|
2006-11-20 |
2009-08-03 |
이데미쓰 고산 가부시키가이샤 |
유기 전계 발광 소자
|
|
US7825261B2
(en)
|
2006-12-05 |
2010-11-02 |
National Taiwan University |
Indazole compounds
|
|
RS55735B1
(sr)
|
2007-08-03 |
2017-07-31 |
Summit (Oxford) Ltd |
Kombinacije lekova za lečenje dišenove mišićne distrofije
|
|
KR20100115789A
(ko)
|
2008-02-04 |
2010-10-28 |
머큐리 테라퓨틱스, 인코포레이티드 |
Ａｍｐｋ 조절자
|
|
CA2737694C
(en)
*
|
2008-09-26 |
2013-07-02 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
AU2009307884B2
(en)
|
2008-10-22 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
EP2352374B1
(en)
|
2008-10-29 |
2014-09-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
CN102271509A
(zh)
|
2008-10-31 |
2011-12-07 |
默沙东公司 |
用于抗糖尿病药的新型环苯并咪唑衍生物
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
CN103476258B
(zh)
|
2011-02-25 |
2017-04-26 |
默沙东公司 |
用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物
|